Shengxiang Biotech, Haoyuan Medical, and other newly established venture capital funds

2026-03-30 02:03:44

On March 30, People’s Finance News reported that the Qichacha APP shows that recently, Guangzhou Shengquan Baijie Venture Capital Fund Partnership (Limited Partnership) was established, with a capital contribution of 150 million yuan. The business scope includes: venture capital (limited to investing in unlisted companies); engaging in equity investment, investment management, asset management, and other activities through private equity funds. Qichacha’s equity penetration shows that this enterprise is co-funded by Shengxiang Biology, Haoyuan Pharmaceuticals, Lai Mei Pharmaceuticals, and others.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes